Results 131 to 140 of about 2,005,614 (317)

Computer and Information Services Newsletter, Special Training Edition, September 1991 [PDF]

open access: yes, 1991
University of Minnesota. Computer and Information Services. (1991). Computer and Information Services Newsletter, Special Training Edition, September 1991.
University of Minnesota. Computer and Information Services
core  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Centers for Medicare & Medicaid Services statistics [PDF]

open access: yes, 2003
Annual; Description based on: 2003; title from PDF cover (viewed Sept. 19, 2005).; Latest issue consulted: 2007 (viewed Apr. 22, 2008).; Harvested from the web on 1/5/04Statistical highlights and information about Medicare, Medicaid, and SCHIP ...
Centers for Medicare & Medicaid Services (U.S.). Office of Research, Development, and Information.
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Department of Corporate and Information Services annual report [PDF]

open access: yes, 1999
Made available by the Library & Archives NT via the Publications (Legal Deposit) Act 2004 (NT).Parent ...

core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Understanding the Pathway of Cancer Information Seeking: Cancer Information Services as a Supplement to Information from Other Sources. [PDF]

open access: yesJ Cancer Educ, 2023
Reifegerste D   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy